Get the latest SNTS - Santarus Inc stock market performance data and financial news.
Get the latest SNTS - Santarus Inc together with stock market performance data and financial news.
Read Jim Cramer's take on Santarus Inc (SNTS) and get his latest thoughts on the company?s performance and outlook
Get the latest SNTS - Santarus Inc stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Dyax and Merck/Santarus get FDA approvals. The U.S. Food and Drug Administration approved two drugs Tuesday night -- a prescription drug for a rare, genetic disorder and an over-the-counter treatment for heartburn.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10636438/1/fda-approves-two-new-drugs-biobuzz.html
The two will jointly develop and market two investigational pain relievers.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10392980/1/adolor-pfizer-ink-rd-deal.html
The lawsuit is filed in response to Par's pursuit of a generic version of heartburn drug Zegerid.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10379519/1/santarus-sues-par-pharma.html
Acid reflux treatment Zegerid boosts second-quarter results, but the company pulls 2008 sales guidance.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10372558/1/santarus-posts-narrower-loss.html
The drug company will co-promote Victory Pharma's Naprelan.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10365725/1/santarus-climbs-on-promo-deal.html
Connect with TheStreet